Regulations.gov document
Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics…
Notice · FDA-2011-D-0611 · posted May 13, 2015
Key facts
| Document ID | FDA-2011-D-0611-0055 |
|---|---|
| Title | Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2011-D-0611 |
| Posted | May 13, 2015 |
| Federal Register citation | FR 80 27321 |
| FR document number | 2015-11528 |
| Comment period opens | May 13, 2015 |
| Comments due | Jul 14, 2015 |
| Effective date | May 13, 2015 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: